Annual Report 2022

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2022 91 The United Laboratories International Holdings Limited Annual Report 2022 5. REVENUE AND SEGMENT INFORMATION (Continued) Segment information (Continued) (b) Other segment information Amounts included in the measurement of segment profit or loss: For the year ended 31 December 2022 Intermediate Bulk Finished products medicine products Unallocated Consolidated RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 Amortisation of intangible assets 1,840 – 17,648 – 19,488 Depreciation of right-of-use assets 3,203 5,065 1,511 1,330 11,109 Depreciation of property, plant and equipment 379,587 85,602 51,912 4,733 521,834 Net loss on disposal of property, plant and equipment 2,194 2,049 147 – 4,390 Written off of property, plant and equipment 32,265 29,208 330 16,373 78,176 Impairment losses (reversed) recognised (5,746) (3,761) 1,260 (3,471) (11,718)